American Journal of Cardiology
Volume 97, Issue 8 , Pages 1192-1197 , 15 April 2006

Usefulness and Safety of Percutaneous Coronary Interventions for Cardiac Transplant Vasculopathy

Received 5 July 2005 ,Revised 8 November 2005 ,Accepted 8 November 2005.

References 

  1. Keogh AM, Valantine HA, Hunt SA, Schroeder JS, McIntosh N, Oyer PE, et al. Impact of proximal or midvessel discrete coronary artery stenoses on survival after heart transplantation . J Heart Lung Transplant . 1992;11:892–901
  2. Gao SZ , Hunt SA , Schroeder JS , Alderman E , Hill IR , Stinson EB . Does rapidity of development of transplant coronary artery disease portend a worse prognosis? . J Heart Lung Transplant . 1994;13:1119–1124
  3. Gallo P, Agozzino L, Angelini A, Arbustini E, Bartoloni G, Bernucci P, et al  Causes of late failure after heart transplantation (a ten-year survey) . J Heart Lung Transplant . 1997;16:1113–1121
  4. Gao SZ , Alderman EL , Schroeder JS , Silverman JF , Hunt SA . Accelerated coronary vascular disease in the heart transplant patient (coronary arteriographic findings) . J Am Coll Cardiol . 1988;12:334–340
  5. Kobashigawa J . What is the optimal prophylaxis for treatment of cardiac allograft vasculopathy? . Curr Control Trials Cardiovasc med . 2000;1:166–171
  6. Srivastava R , Keck BM , Bennett LE , Hosenpud JD . The results of cardiac retransplantation (an analysis of the Joint International Society for Heart and Lung Transplantation/United Network for Organ Sharing Thoracic Registry) . Transplantation . 2000;70:606–612
  7. Musci M, Pasic M, Meyer R, Loebe M, Wellnhofer E, Weng Y, et al. Coronary artery bypass grafting after orthotopic heart transplantation . Eur J Cardiothorac Surg . 1999;16:163–168
  8. Kobashigawa JA, Katznelson S, Laks H, Johnson JA, Yeatman L, Wang XM, et al  Effect of pravastatin on outcomes after cardiac transplantation . N Engl J Med . 1995;333:621–627
  9. Maggard MA, Johnson C, Wang T, Terasaki P, Kupiec-Weglinski JW, Busuttil RW, et al. Inhibition of transplant vasculopathy is associated with attenuated host allo-antibody response . Transplant Proc . 1999;31:728–729
  10. Maggard MA, Ke B, Wang T, Kaldas F, Seu P, Busuttil RW, et al. Effects of pravastatin on chronic rejection of rat cardiac allografts . Transplantation . 1998;65:149–155
  11. Wenke K, Meiser B, Thiery J, Nagel D, von Scheidt W, Steinbeck G, et al. Simvastatin reduces graft vessel disease and mortality after heart transplantation (a four-year randomized trial) . Circulation . 1997;96:1398–1402
  12. Sandhu JS, Uretsky BF, Reddy PS, Denys BG, Ruffner RJ, Breisblatt WM, et al  Potential limitations of percutaneous transluminal coronary angioplasty in heart transplant recipients . Am J Cardiol . 1992;69:1234–1237
  13. Christensen BV , Meyer SM , Iacarella CL , Kubo SH , Wilson RF . Coronary angioplasty in heart transplant recipients (a quantitative angiographic long-term follow-up study) . J Heart Lung Transplant . 1994;13:212–220
  14. Halle AA, DiSciascio G, Massin EK, Wilson RF, Johnson MR, Sullivan HJ, et al  Coronary angioplasty, atherectomy and bypass surgery in cardiac transplant recipients . J Am Coll Cardiol . 1995;26:120–128
  15. Johnson TH , Das GS , McGinn AL , Christensen BV , Meyer SM , Wilson RF . Physiologic assessment of the coronary collateral circulation in transplanted human hearts . J Heart Lung Transplant . 1994;13:840–846
  16. von Scheidt W , Uberfuhr P , Reichart B , Steinbeck G . The role of PTCA in the management of focal critical lesions in transplant coronary artery disease . Transplant Proc . 1995;27:1936–1938
  17. Redonnet M, Tron C, Koning R, Bouchart F, Cribier A, Soyer R, et al. Coronary angioplasty and stenting in cardiac allograft vasculopathy following heart transplantation . Transplant Proc . 2000;32:463–465
  18. Keogh A, Richardson M, Ruygrok P, Spratt P, Galbraith A, O’Driscoll G, et al. Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years (a randomized clinical trial) . Circulation . 2004;110:2694–2700
  19. Mancini D, Pinney S, Burkhoff D, LaManca J, Itescu S, Burke E, et al. Use of rapamycin slows progression of cardiac transplantation vasculopathy . Circulation . 2003;108:48–53
  20. Ryan TJ, Bauman WB, Kennedy JW, Kereiakes DJ, King SB, McCallister BD, et al. Guidelines for percutaneous transluminal coronary angioplasty (a report of the American Heart Association/American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary Angioplasty)) . Circulation . 1993;88:2987–3007
  21. Billingham ME, Cary NR, Hammond ME, Kemnitz J, Marboe C, McCallister HA, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection (the International Society for Heart Transplantation) . J Heart Transplant . 1990;9:587–593
  22. Uretsky BF, Murali S, Reddy PS, Rabin B, Lee A, Griffith BP, et al. Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone . Circulation . 1987;76:827–834
  23. Ratkovec RM, Wray RB, Renlund DG, O’Connell JB, Bristow MR, Gay WA, et al  Influence of corticosteroid-free maintenance immunosuppression on allograft coronary artery disease after cardiac transplantation . J Thorac Cardiovasc Surg . 1990;100:6–12
  24. Pennock JL, Oyer PE, Reitz BA, Jamieson SW, Bieber CP, Wallwork J, et al. Cardiac transplantation in perspective for the future (survival, complications, rehabilitation, and cost) . J Thorac Cardiovasc Surg . 1982;83:168–177
  25. Barnhart GR, Pascoe EA, Mills AS, Szentpetery S, Eich DM, Mohanakumar T, et al. Accelerated coronary arteriosclerosis in cardiac transplant recipients . Transplant Rev (Orlando) . 1987;1:31–46
  26. Jain SP, Ramee SR, White CJ, Mehra MR, Ventura HO, Zhang S, et al. Coronary stenting in cardiac allograft vasculopathy . J Am Coll Cardiol . 1998;32:1636–1640
  27. Sharifi M , Siraj Y , O’Donnell J , Pompili VJ . Coronary angioplasty and stenting in orthotopic heart transplants (a fruitful act or a futile attempt?) . Angiology . 2000;51:809–815
  28. Wong PM, Piamsomboon C, Mathur A, Chastain HD, Singh DJ, Liu MW, et al. Efficacy of coronary stenting in the management of cardiac allograft vasculopathy . Am J Cardiol . 1998;82:239–241
  29. Boffa GM, Livi U, Grassi G, Casarotto D, Isabella G, Cardaioli P, et al. Angiographic presentation of coronary artery spasm in heart transplant recipients . Int J Cardiol . 2000;73:67–74

PII: S0002-9149(06)00042-7

doi: 10.1016/j.amjcard.2005.11.038

American Journal of Cardiology
Volume 97, Issue 8 , Pages 1192-1197 , 15 April 2006

Article Tools

* Image Usage & Resolution